Special verification opinions of Huatai United Securities Co., Ltd. on the deposit and actual use of Bloomage Biotechnology Corporation Limited(688363) raised funds
Huatai United Securities Co., Ltd. (hereinafter referred to as “Huatai united” or “sponsor”) as the sponsor of Bloomage Biotechnology Corporation Limited(688363) (hereinafter referred to as ” Bloomage Biotechnology Corporation Limited(688363) ” or “company”) for initial public offering of shares and listing on the science and innovation board, in accordance with the rules for listing shares on the science and Innovation Board of Shanghai Stock Exchange The guidelines for the supervision of listed companies No. 2 – regulatory requirements for the management and use of funds raised by listed companies, the measures for the continuous supervision of companies listed on the science and Innovation Board (for Trial Implementation) and other laws and regulations have verified the deposit and use of funds raised by Bloomage Biotechnology Corporation Limited(688363) initial public offering of A-Shares in 2021. The details are as follows: I. Basic information of raised funds
(I) actual amount of funds raised and time of funds in place
The company issued 49562556 ordinary shares in RMB for the first time, with an issue price of 47.79 yuan / share. As of October 30, 2019, the total amount of funds raised by the company was 236859455124 yuan, deducting the underwriting fee and recommendation fee of 926 Shanghai Pudong Development Bank Co.Ltd(600000) 0 yuan. The amount of funds raised by the company on October 30, 2019 was 227593455124 yuan, deducting the recommendation fee, audit evaluation and capital verification fee paid with self raised funds After the total amount of lawyer fees and other fees related to the issuance is 2698012624 yuan, the net amount of raised funds is 224895442500 yuan.
The above net amount of raised funds has been verified in the capital verification report (ztyz (2019) No. 110zc0182) of Grant Thornton Certified Public Accountants (special general partnership).
(II) use and balance of raised funds in 2021
1. Balance of raised funds as of December 31, 2021
Project amount (RMB)
As of December 31, 2020, the balance of actually raised funds was 152037497358
Less: the total amount of projects directly invested by raising funds in 2021 is 72113524143
Less: service charge expenditure in 2021: 681252
Plus: interest and wealth management income in 20212651025890
Balance on December 31, 2021: 82574317853
2. Use of raised funds
(1) As of December 31, 2020, the company has invested 78077678800 yuan in projects invested with raised funds, and 72113524143 yuan in projects invested with raised funds in 2021. As of December 31, 2021, the company has invested 150191202943 yuan of raised funds in projects invested with raised funds.
(2) As of December 31, 2021, the balance of the raised funds account is 82574317853 yuan, including 19299317853 yuan of bank deposit, 20000000000 yuan of seven-day notice deposit, 17000000000 yuan of negotiable certificate of deposit, 20000000000 yuan of Huatai Securities Co.Ltd(601688) brokerage income certificate and 6275000000 yuan of international letter of credit deposit.
2、 Deposit and management of raised funds
(I) management of raised funds
In order to standardize the management and use of raised funds and protect the rights and interests of investors, the company has formulated Bloomage Biotechnology Corporation Limited(688363) raised funds management system in accordance with laws and regulations and in combination with the actual situation of the company, which clearly stipulates the storage, use, purpose change, management and supervision of the special account for raised funds.
According to the Bloomage Biotechnology Corporation Limited(688363) raised funds management system and in combination with the business needs, the company and its subsidiaries implementing the raised funds investment project have signed the supervision agreement of the raised funds special account with the sponsor and the supervision Bank of the raised funds special account in October 2019 and March 2021 to strictly approve the use of the raised funds, so as to ensure the special use of the raised funds. There is no significant difference between the aforesaid agreement and the tripartite supervision agreement (model) on the storage of special account for raised funds of Shanghai Stock Exchange. As of December 31, 2021, the company has deposited and used the raised funds in strict accordance with the provisions of the regulatory agreement.
(II) storage of raised funds in special account
As of December 31, 2021, the specific deposit of the special account for raised funds is as follows:
Deposit bank account number account category storage balance
(RMB)
Beijing Rural Commercial Bank Co., Ltd. 1803 China Baoan Group Co.Ltd(000009) 210 special deposit 24290500 account of Si Jianguomen sub branch
Bank of Dalian Co., Ltd. Beijing feng11512600 China Baoan Group Co.Ltd(000009) 6 special deposit 12840546136tai sub branch account
Bank Of Beijing Co.Ltd(601169) East Chang’an Street sub branch 2 Shenzhen Guohua Network Security Technology Co.Ltd(000004) 1791400030773476 special deposit account 20557834496
Deposit bank account number account category storage balance
(RMB)
China Merchants Bank Co.Ltd(600036) Jinan Branch 531902278110905 special deposit 22876646721 bank account
Total 56299317853
Note: 1. In addition to the funds deposited in the special account for raised funds, another 6275000000 yuan is deposited in the L / C margin account associated with the raised funds account opened by China Merchants Bank Co.Ltd(600036) Jinan Branch for the opening of international L / C of raised investment projects; There is 20000000000 yuan transferred out for the purchase of Huatai Securities Co.Ltd(601688) brokerage income certificate.
2. Among the above deposit balances, RMB 2651025890 has been included in the interest and financial management income of the special account for raised funds in 2021, and RMB 681252 has been deducted from the service charge in 2021.
3、 Actual use of raised funds this year
(I) use of funds for projects invested with raised funds
The actual use of the company’s raised funds in 2021 is detailed in “Schedule 1: comparison table of the use of raised funds”.
(II) early investment and replacement of raised investment projects
On April 28, 2020, the company held the 14th meeting of the first board of directors and the 9th meeting of the first board of supervisors, respectively, deliberated and approved the proposal on replacing the self raised funds invested in advance with the raised funds, and agreed to use the raised funds of 951963 million yuan to replace the self raised funds invested in the investment projects invested in advance with the raised funds. According to the verification report on Bloomage Biotechnology Corporation Limited(688363) pre investment of raised funds in projects with self raised funds (ztzz (2020) No. 110za4095) issued by Zhitong Certified Public Accountants (special general partnership) on April 28, 2020, as of March 31, 2020, The actual investment of the company’s self raised fund is RMB 956300. As of the date of issuance of this special verification opinion, the company has completed the use of raised funds to replace the self raised funds invested in raised investment projects of RMB 951963 million.
(III) temporary replenishment of working capital with idle raised funds
As of December 31, 2021, the company does not temporarily supplement working capital with idle raised funds.
(IV) cash management of idle raised funds and investment in related products
On December 8, 2021, the company held the 28th meeting of the first board of directors and the 23rd Meeting of the first board of supervisors, deliberated and adopted the proposal on continuing to use idle raised funds for cash management, and agreed that the company would not affect the construction of investment projects and the use arrangement of raised funds, and effectively control risks, Within 12 months from the date of deliberation and approval by the board of directors, the temporarily idle raised funds up to RMB 700 million shall be subject to cash management, and the principal guaranteed investment products sold by financial institutions with high safety, good liquidity and legal business qualification shall be purchased. The amount of RMB 700 million can be recycled and rolled.
As of December 31, 2021, the total amount of negotiable certificates of deposit and securities firm income certificates that have not been redeemed by the company is 57000000000 yuan. The details are as follows:
Unit: RMB
Partner’s product name product type amount starting and ending period estimated annualized
Name rate of return
Bank of Beijing call deposit 2000000000 flexible term 2.025%
that ‘s ok
Bank of Beijing call deposit 2000000000 flexible term 2.025%
that ‘s ok
Bank of Beijing call deposit 1000000000 flexible term 2.10%
that ‘s ok
Bank of Beijing call deposit 5000000000 flexible term 2.10%
that ‘s ok
Bank of Beijing call deposit 10000000000 flexible term 2.10%
that ‘s ok
China Merchants Bank transferable certificate of deposit deposit 20000 China Vanke Co.Ltd(000002) 021 / 6 / 2 – 3.81%
Line 2022 / 3 / 18
China Merchants Bank transferable certificate of deposit deposit deposit 60000 China Vanke Co.Ltd(000002) 021 / 7 / 2 – 3.43%
Line 2022 / 6 / 12
China Merchants Bank transferable certificate of deposit deposit 10000 China Vanke Co.Ltd(000002) 021 / 7 / 1 – 3.60%
Line 2022 / 4 / 16
China Merchants Bank transferable certificate of deposit deposit 30000 China Vanke Co.Ltd(000002) 021 / 8 / 19 – 3.30%
Line 2022 / 6 / 25
China Merchants Bank transferable certificate of deposit deposit 10000 China Vanke Co.Ltd(000002) 021 / 12 / 10 – 3.30%
Line 2023 / 11 / 19
China Merchants Bank transferable certificate of deposit deposit deposit 1000000000
